<p>ADAMTS13 from HEK293 cells was incubated with the mAb Wh2-11-1 and VWF under the following conditions: (I) ADAMTS13 was treated with VWF at 37°C prior to addition of Wh2-11-1. (II) ADAMTS13 was treated with Wh2-11-1 at 37°C followed by the addition of VWF. (III) ADAMTS13 was treated with VWF at 4°C prior to addition of Wh2-11-1. (IV) ADAMTS13 was treated with Wh2-11-1 at 4°C followed by the addition of VWF. *Reactivity of ADAMTS13 to Wh2-11-1 is significantly higher (p<.001) in the presence of VWF at 37°C. **There is no significant difference between the reactivity of Wh2-11-1 to ADAMTS13 in the presence or absence of VWF at 4°C (p = 0.083). Binding of mAb was monitored by flow cytometry. The figure represents data from one of five indep...
(A) 5 n ADAMTS-13 or thrombin-cleaved ADAMTS-13 (ADAMTS-13/FIIa) was incubated at 37 °C with 5 μ VWF...
<p>A. Recombinant ADAMTS13 cleaves the A2 domain of VWF whereby 176 kDa and 140 kDa bands appear (la...
The haemostatic potential of von Willebrand factor, a glycoprotein expressed by endothelial cells as...
<p>(A) Serial dilutions of the mAb Wh2-11-1 were allowed to bind to ADAMTS13 from human embryonic ce...
<p>(A) Activity of wild-type (▪) and the P475S mutant (•) ADAMTS13s were measured by the FRET-VWF73 ...
<p>Summary of 8 mAbs to VWF and their effects on VWF proteolysis by ADAMTS13.</p
Background: ADAMTS-13 proteolytic activity is controlled by the conformation of its substrate, von W...
A disintegrin and metalloprotease with thrombospondin motifs 13 (ADAMTS13) is a metalloprotease that...
von Willebrand factor (VWF) is a key player in hemostasis, acting as a carrier for factor VIII and c...
<p>(<b>A</b>) Cleavage of VWF-A2 (100 nM) by ADAMTS-13 (10 nM) after 1 hr incubation in the presence...
Blood loss is prevented by the multi-domain glycoprotein von Willebrand factor (VWF), which binds ex...
<p>Endothelial cell lysates were incubated with purified VWF. Cell buffer incubated with VWF was use...
Summary. Background: ADAMTS-13 proteolytic activity is controlled by the conformation of its substra...
(A) 6 n ADAMTS-13, 60 n thrombin-cleaved ADAMTS-13 (ADAMTS-13/FIIa) or 60 n thrombin-cleaved ADAMTS-...
<p>Recombinant VWF-R1597W (150 nM) was incubated with 0 or 100 µg/ml SZ34 at 37°C for 30 min and the...
(A) 5 n ADAMTS-13 or thrombin-cleaved ADAMTS-13 (ADAMTS-13/FIIa) was incubated at 37 °C with 5 μ VWF...
<p>A. Recombinant ADAMTS13 cleaves the A2 domain of VWF whereby 176 kDa and 140 kDa bands appear (la...
The haemostatic potential of von Willebrand factor, a glycoprotein expressed by endothelial cells as...
<p>(A) Serial dilutions of the mAb Wh2-11-1 were allowed to bind to ADAMTS13 from human embryonic ce...
<p>(A) Activity of wild-type (▪) and the P475S mutant (•) ADAMTS13s were measured by the FRET-VWF73 ...
<p>Summary of 8 mAbs to VWF and their effects on VWF proteolysis by ADAMTS13.</p
Background: ADAMTS-13 proteolytic activity is controlled by the conformation of its substrate, von W...
A disintegrin and metalloprotease with thrombospondin motifs 13 (ADAMTS13) is a metalloprotease that...
von Willebrand factor (VWF) is a key player in hemostasis, acting as a carrier for factor VIII and c...
<p>(<b>A</b>) Cleavage of VWF-A2 (100 nM) by ADAMTS-13 (10 nM) after 1 hr incubation in the presence...
Blood loss is prevented by the multi-domain glycoprotein von Willebrand factor (VWF), which binds ex...
<p>Endothelial cell lysates were incubated with purified VWF. Cell buffer incubated with VWF was use...
Summary. Background: ADAMTS-13 proteolytic activity is controlled by the conformation of its substra...
(A) 6 n ADAMTS-13, 60 n thrombin-cleaved ADAMTS-13 (ADAMTS-13/FIIa) or 60 n thrombin-cleaved ADAMTS-...
<p>Recombinant VWF-R1597W (150 nM) was incubated with 0 or 100 µg/ml SZ34 at 37°C for 30 min and the...
(A) 5 n ADAMTS-13 or thrombin-cleaved ADAMTS-13 (ADAMTS-13/FIIa) was incubated at 37 °C with 5 μ VWF...
<p>A. Recombinant ADAMTS13 cleaves the A2 domain of VWF whereby 176 kDa and 140 kDa bands appear (la...
The haemostatic potential of von Willebrand factor, a glycoprotein expressed by endothelial cells as...